我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

Kidney Transporters Medication Discovery, Development, and Safety

Hilary Mantel

The kidney is an excretory organ having influx transporters on the basolateral membrane of proximal tubular cells and efflux transporters on the apical membrane. Cross-species changes in kidney transporter expression, function, location, and homology are crucial factors. DIKI is caused mostly by intracellular drug accumulation or metabolites and is accompanied with kidney histological abnormalities and a rise in serum creatinine (Scr). It is critical to determine whether a rise in Scr is caused by DIKI or by indirect transporter inhibition, which results in reversible and transitory drug-induced Scr increase [DICI] without histopathological abnormalities. Finally, in vitro and in vivo animal models can anticipate unexpected changes in systemic exposure and the effect of kidney transporters.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。